XML 45 R10.htm IDEA: XBRL DOCUMENT v2.3.0.15
Other Real Estate Property Investments
9 Months Ended
Sep. 30, 2011
Other Real Estate Property Investments 
Other Real Estate Property Investments

(4)         Other Real Estate Property Investments

 

A summary of other real estate acquisitions for the nine months ended September 30, 2011 follows (in thousands):

 

 

 

Consideration

 

Assets Acquired

 

Segment

 

Cash Paid

 

Debt
Assumed

 

Noncontrolling
Interest

 

Real Estate

 

Net
Intangibles

 

Life science

 

$

84,087

 

$

57,869

 

$

 

$

133,040

 

$

8,916

 

Medical office

 

29,743

 

 

1,500

 

26,191

 

5,052

 

 

 

$

113,830

 

$

57,869

 

$

1,500

 

$

159,231

 

$

13,968

 

 

See discussion of the purchase and consolidation of HCP Ventures II in Note 8.

 

During the nine months ended September 30, 2011, the Company funded an aggregate of $87 million for construction, tenant and other capital improvement projects, primarily in its life science and medical office segments. During the nine months ended September 30, 2011, two of the Company’s life science facilities located in South San Francisco were placed in service representing 88,000 square feet.

 

A summary of real estate acquisitions for the nine months ended September 30, 2010 follows (in thousands):

 

 

 

Consideration

 

Assets Acquired

 

Segment

 

Cash Paid

 

Debt
Assumed

 

DownREIT
Units(1)

 

Real Estate

 

Net
Intangibles

 

Senior housing

 

$

124,935

 

$

 

$

 

$

124,565

 

$

370

 

Life science

 

21,843

 

 

7,341

 

23,998

 

5,186

 

Medical office

 

12,017

 

5,352

 

1,926

 

15,734

 

3,561

 

 

 

$

158,795

 

$

5,352

 

$

9,267

 

$

164,297

 

$

9,117

 

 

(1)          Non-managing member limited liability company units.

 

During the nine months ended September 30, 2010, the Company funded an aggregate of $97 million for construction, tenant and other capital improvement projects, primarily in its life science segment. During the nine months ended September 30, 2010, four of the Company’s life science facilities located in South San Francisco were placed into service representing 354,000 square feet.